Nurix Therapeutics | 8-K: Current report
Nurix Therapeutics | 8-K: Current report
Nurix Therapeutics | 8-K: Current report
Nurix Therapeutics | DEFA14A: Others
Nurix Therapeutics | DEF 14A: Definitive information statements
Nurix Therapeutics | 8-K: Current report
Nurix Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Nurix Therapeutics | 8-K: Current report
Nurix Therapeutics | 8-K: Current report
Nurix Therapeutics | 8-K: Current report
Nurix Therapeutics | 8-K: Current report
Nurix Therapeutics | 8-K: Current report
Nurix Therapeutics | 8-K: Nurix Therapeutics Reports Third Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
Nurix Therapeutics | 8-K: Current report
Nurix Therapeutics | 8-K: Nurix Therapeutics Reports Second Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
Nurix Therapeutics | 8-K: Current report
Nurix Therapeutics | 8-K: Nurix Therapeutics Reports First Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
Nurix Therapeutics | 8-K: Current report
Nurix Therapeutics | DEFA14A: Others
Nurix Therapeutics | DEF 14A: Definitive proxy statements
No Data